Serum YKL-40 (Chitinase-3-Like Protein 1) Compared to APRI and FIB-4 in Predicting Liver Fibrosis in Children with Chronic Hepatitis C
<p><strong>Background</strong>: Liver fi brosis is a critical factor for the treatment policy and its outcome in chronic hepatitis C virus (HCV) infection. Although liver biopsy represents the gold standard for evaluating fibrosis, it remains an invasive procedure with inherent ris...
Saved in:
Main Authors: | Mostafa Mohamed Sira (Author), Hanaa Ahmed El-Araby (Author), Enas Mohamed Ghoneim (Author), Hatem Abdel-Sattar Konsowa (Author), Eman Hosny El-Mwafy (Author), Ibrahim A Elhenawy (Author) |
---|---|
Format: | Book |
Published: |
Archives of Hepatitis Research - Peertechz Publications,
2016-12-30.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Chitinase-3-Like Protein 1 (YKL-40) Is a New Biomarker of Inflammation in Psoriasis
by: Joanna Salomon, et al.
Published: (2017) -
Chitinase-3-like Protein 1 (YKL-40): A New Biomarker of Inflammation in Pyoderma Gangrenosum
by: Alina Jankowska-Konsur, et al.
Published: (2022) -
FIB-4 and APRI scores for progressive liver fibrosis diagnosis in children with biliary atresia
by: Hongyu Lyu, et al.
Published: (2024) -
The Role of Chitinase-3-like Protein-1 (YKL40) in the Therapy of Cancer and Other Chronic-Inflammation-Related Diseases
by: Ming-Cheng Chang, et al.
Published: (2024) -
Determination of liver damage indices APRI and FIB-4 score in adolescents with juvenile idiopathic arthritis
by: L.A. Strashok, et al.
Published: (2020)